These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10640902)

  • 1. Invasive potential and substrate dependence of attachment in the dunning R-3327 rat prostate adenocarcinoma model.
    Donald CD; Montgomery DE; Emmett N; Cooke DB
    Invasion Metastasis; 1998-1999; 18(4):165-75. PubMed ID: 10640902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model.
    Mohler JL; Levy F; Sharief Y
    Cancer Res; 1991 Dec; 51(24):6580-5. PubMed ID: 1742730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-metastatic activities of all-trans retinoic acid, indole-3-carbinol and (+)-catechin in Dunning rat invasive prostate adenocarcinoma cells.
    Nwankwo JO
    Anticancer Res; 2002; 22(6C):4129-35. PubMed ID: 12553043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoskeletal organization and cell motility correlates with metastatic potential and state of differentiation in prostate cancer.
    Donald CD; Cooper CR; Harris-Hooker S; Emmett N; Scanlon M; Cooke DB
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1033-8. PubMed ID: 11785653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
    Webber MM; Waghray A
    Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD98059-inhibited invasion of Dunning rat prostate cancer cells involves suppression of motility but not MMP-2 or uPA secretion.
    Suthiphongchai T; Phimsen S; Sakulkhu U; Tohtong R
    Oncol Rep; 2006 Jun; 15(6):1605-10. PubMed ID: 16685402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic methylation patterns of the Dunning R-3327 prostate adenocarcinoma system.
    Blount LV; Cooke DB
    Cancer Lett; 1996 Jan; 98(2):213-8. PubMed ID: 8556711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion and invasion potential of rat prostatic cancer cells: correlation with metastatic potential.
    Cooper CR; Donald C; Emmett N; Harris-Hooker S; Cooke DB
    Invasion Metastasis; 1993; 13(4):178-84. PubMed ID: 8034439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
    Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
    Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
    Nakajima M; Lotan D; Baig MM; Carralero RM; Wood WR; Hendrix MJ; Lotan R
    Cancer Res; 1989 Apr; 49(7):1698-706. PubMed ID: 2538232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of castanospermine on the metastatic properties of prostate cancer cells.
    Yee CS; Schwab ED; Lehr JE; Quigley M; Pienta KJ
    Anticancer Res; 1997; 17(5A):3659-63. PubMed ID: 9413219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells.
    Abraham S; Zhang W; Greenberg N; Zhang M
    J Urol; 2003 Mar; 169(3):1157-61. PubMed ID: 12576872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection.
    Luo J; Lubaroff DM; Hendrix MJ
    Cancer Res; 1999 Aug; 59(15):3552-6. PubMed ID: 10446959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.
    Halin S; Wikström P; Rudolfsson SH; Stattin P; Doll JA; Crawford SE; Bergh A
    Cancer Res; 2004 Aug; 64(16):5664-71. PubMed ID: 15313905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell substratum modulates responses of preosteoblasts to retinoic acid.
    Traianedes K; Ng KW; Martin TJ; Findlay DM
    J Cell Physiol; 1993 Nov; 157(2):243-52. PubMed ID: 8227157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of a metastatic variant to the liver of human rectal adenocarcinoma cell line RCM-1.
    Komada N; Nabeshima K; Koita H; Kataoka H; Muraoka K; Koono M
    Invasion Metastasis; 1993; 13(1):38-49. PubMed ID: 8407210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model.
    Lowe FC; Isaacs JT
    Cancer Res; 1984 Feb; 44(2):744-52. PubMed ID: 6537899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of metastatic potential of high-metastatic Lewis lung carcinoma cells by vanadate, an inhibitor of tyrosine phosphatase, through inhibiting cell-substrate adhesion.
    Takenaga K
    Invasion Metastasis; 1996; 16(2):97-106. PubMed ID: 9030244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.